Effects of bisphosphonates and statins on tibial bone healing in rats with osteoporosis induced by dexamethasone treatment;Efeitos de bifosfonatos e estatinas na reparação defraturasemtíbiasderatascomosteoporoseinduzida comdexametasona

Revista de Ciencias Farmaceuticas Basica e Aplicada

Volumn 29, Issue 2, 2008, Pages 201-207

  Ferreira Junior D B ^a   Pinto, A S ^a   Del Carlo, R J ^a   Fonseca, C C ^a   Oliveira, T T ^a   Cardoso, C A ^a   Amaral, G G ^a   Lima, L R P ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Alendronate; Atorvastatin; Bone recovery; Lovastatin; Osteoporosis; Risedronate

Indexed keywords

ALBUMIN; ALENDRONIC ACID; ALKALINE PHOSPHATASE; ATORVASTATIN; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DEXAMETHASONE; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PHOSPHORUS; PROTEIN; RISEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; CALLUS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FRACTURE HEALING; FRACTURE NONUNION; MORPHOMETRICS; NONHUMAN; OSTEOPOROSIS; RAT; TIBIA FRACTURE; TRABECULAR BONE; WISTAR RAT;

EID: 67049095782     PISSN: 18084532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Altunda H, Gursoy B. The influence of alendronate on bone formation after autogenous free bone. Oral Surg Oral Pled Oral Pathol Oral Radiol Endod 2005; 99:285-91.
2. Altunda H, Guvener O. The effect of alendronate on resorption of the alveolar bone following tootli extraction. Int J Oral Maxillofac Surg 2004; 33:286-93.
3. Benford HL, Mcgowan NWA, Helfrich MH, Nutall ME, Roger MJ. Visualization of bisphosphonate-induced caspase-3-activity in apoptotic osteoclasts in vitro. Bone 2001; 28(5):465-73.
4. Bikle DD, Halloran B, Fong L, Steinbach L, Shellito J. Elevated 1,25-dihydroxyvitamin D levels in patients with chronic obstructive pulmonary disease treated with prednisone. JClin EndocrinolMetab 1993; 76(2):456-61.
5. Brandli DW, Golde G, Greenwald M, Silverman ST. Glucocorticoid-induced osteoporosis: a cross-sectional study. Steroids 1991; 56:518-23.
6. Calvert CA, Cornelius LM. Corticosteroids hormones: endogenous regulation and the effects of exogenous administration. Vet Med 1990; 84:810-23.
7. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, Lacroix AZ. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women's health initiative randomized trial. JAMA 2003; 290:1729-38.
8. Eckardt H, Christensen KS, Lind M, Hansen ES, Hall DWR, Hvid I. Recombinant human bone morphogenetic protein 2 enhances bone healing in an experimental model of fractures at risk of non-union. Injury 2005; 36: 489-94.
9. Fini M, Giavaresi G, Torricelli P, Borsari V, Giardino R, Nicolini A, Carpi A. Osteoporosis and biomaterial osteointegration. BiomedPharmacother 2004; 58:487-93.
10. Fogelman I, Pearson DW, Bessent RG, Tofe AJ, Francis MD. A comparison of skeletal uptake of three diphosphonates by whole body retention. JNuclMed 1981; 22:880-3.
11. Hamdy NAT. Role of bisphosphonates in metabolic bone diseases. Trends Endocrinol Metab 1993; 4:19-25.
12. Hench LL. Biomaterials: a forecast for the future. Biomaterials 1998; 19:1419-23.
13. Im G, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferationand maturationby bisphosphonates. Biomaterials 2004; 25:4105-15.
14. Lanna CMM, Montenegro RM, Paula FJA. Fisiopatologia da osteoporose induzida por glicocorticoide. Arq Bras EndocrinolMetabol 2003; 47(1):9-18.
15. Leem K, Park SY, Lee DH, Kirn H. Lovastatin increases longitudinal bone growtli and bone morphogenetic protein-2 levels in tlie growth plate of Sprague-Dawley rats. Eur J Pediatr 2002; 161:406-7.
16. Lehman RA, Kuklo TR, Freedman BA, Cowart JR, Mense MG, Riew D. The Effect of alendronate sodium on spinal fusion: a rabbit model. Spine J 2004; 4:36-43.
17. Li X, Cui Q, Kao C, Wang GJ, Baliana G. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARy2 and increasing Cbfal/Runx2 expression in bone marrow mesenchymal cell cultures. Bom 2003;33:652-9.
18. Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of gtp-binding proteins, including ras. J Bone Miner Res 1998; 13:581-9.
19. Maeda T, Kawane T, Horiuchi N. Statins augment vascular endothelial growtli factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology 2003; 144(2):681-92.
20. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001; 280:874-7.
21. Mendonza MLH. Classification de la osteoporosis. Factores de riesgo. Clinica y diagnostico diferencial. An Sist San it Navar 2003; 26(3):29-52.
22. Muller SS, Curcelli EC, SardenbergT, Zuccon A, De Crudis Junior JL, Padovani CR. Analise clinica e biomecanica do efeito do diclofenaco sodico na consolidacao da fratura da tibia no rato. Acta Ortop Bras 2004; 12(4): 197-204.
23. Mundy GR. Statins and their potential for osteoporosis. Bone 2001; 29(6):495-7.
24. Mundy GR, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286:1946-9.
25. Namkung-Matthai H, Appleyard R, Jansen J, Lin H, Maastricht S, Swain M. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 2001; 28(l):80-6.
26. Patschan D, Loddenkemper K, Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 2001; 29(6):498-505.
27. Pinto AS, Oliveira TT, Del Carlo RJ, Nagem TJ, Fonseca CC, Moraes GHK, Ferreira DBJ, Cardoso AC. Efeitos de tratamento combinado de alendronato de sodio, atorvastatina calcica e ipriflavona na osteoporose induzida com dexametasona em ratas. Rev Bras Gene Farm 2006; 42:99-107.
28. Reid IR. Glucocorticoid osteoporosis-mechanisms and management. Eur J Endocrinol 1997; 137(3):209-17.
29. Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Rasclike M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone 2002; 30(6):816-22.
30. Uusitalo H, Rantakokko J, Vuorio E, Aro HT. Bone defect repair in immobilization-induced osteopenia: a pQCT, biomechanical, and molecular biologic study in the mouse femur. Bone 2005; 36:142-9.
31. Vitte C, Fleish H, Guenther HL. Bisphophonates induce osteoblasts to secret an inhibitor of osteoclast-mediated resorption. Endocrinology 1996; 137:2324-33.
32. Yonemura K, Hishida A, Kimura M, Watanabe T, KumagaiH. Prednisolone induces an increase in serum calcium concentration: possible involvement of the kidney, the bone, and the intestine. Calcif Tissue Int 1999; 65(4):267-71.